RSSS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RSSS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to act now. The stock is trading below key moving averages, no proprietary buy signal is present, analyst targets have been cut recently, and the recent pattern suggests weak near-term returns. I would not buy here; hold off or wait for a clearer trend reversal.
Technically, RSSS is weak. The MACD histogram is negative at -0.0267, though it is contracting, which suggests bearish momentum is easing but not yet turning positive. RSI_6 at 36.384 is still neutral-to-weak and does not show strong buying pressure. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Price is at 2.1768 pre-market, sitting below the pivot level of 2.343 and closer to support at 2.057 than resistance at 2.63. The short-term stock trend data also points to weakness, with projected downside over the next week and month.
["Lake Street still maintains a Buy rating.", "Roth Capital still maintains a Buy rating.", "Cost controls helped AEBITDA roughly match expectations in the latest quarter.", "Underlying mix reportedly continued to improve.", "New logos and upselling were described as strong."]
["No news in the recent week, so no fresh catalyst is supporting the stock.", "Analysts lowered price targets across the board: $5 to $4, $5 to $3.50, and $5 to $4.", "Q3 revenues were below forecast.", "Q1 revenue fell 4% year over year and missed consensus.", "Churn remains an issue.", "Hedge funds are neutral with no significant buying trend.", "Insiders are neutral with no significant trading trend.", "No recent congress trading data is available.", "The stock trend model suggests downside over the next week and month."]
Latest quarter season: Q3. The latest results were mixed. Revenue came in below forecasts, but AEBITDA roughly matched expectations thanks to good cost controls. Analysts also noted that the company's mix was improving. Earlier, Q1 revenue fell 4% year over year and missed consensus, while new customer logos and upselling were solid but churn remained a concern. Overall, growth trends look soft rather than accelerating.
Recent analyst sentiment remains constructive but clearly less optimistic on valuation. Lake Street, Roth Capital, and Maxim all kept Buy ratings, but all three lowered price targets from $5 to the $3.50-$4 range after mixed or weak quarterly results. The pros view is that execution is fair, cost controls are solid, and the mix/new business trends are improving. The cons view is that revenue missed expectations, churn is still an issue, and analysts are marking down targets because growth is not strong enough to justify prior valuations.
